Trademark: 90790088
Status Date
Wednesday, February 28, 2024
Filing Date
Wednesday, June 23, 2021
Published for Opposition
Tuesday, March 21, 2023
5 Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer
Feb 29, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2024
Sou Extension 1 Granted
Feb 28, 2024
Sou Extension 1 Filed
Feb 28, 2024
Sou Teas Extension Received
Sep 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 30, 2023
Extension Of Time To Oppose Process - Terminated
Apr 20, 2023
Extension Of Time To Oppose Received
Mar 21, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 21, 2023
Published For Opposition
Mar 1, 2023
Notification Of Notice Of Publication E-Mailed
Feb 15, 2023
Approved For Pub - Principal Register
Dec 6, 2022
Teas/Email Correspondence Entered
Dec 6, 2022
Correspondence Received In Law Office
Dec 6, 2022
Teas Response To Office Action Received
Nov 23, 2022
Notification Of Non-Final Action E-Mailed
Nov 23, 2022
Non-Final Action E-Mailed
Nov 23, 2022
Non-Final Action Written
Sep 16, 2022
Teas/Email Correspondence Entered
Sep 15, 2022
Correspondence Received In Law Office
Sep 15, 2022
Teas Response To Office Action Received
Mar 15, 2022
Notification Of Non-Final Action E-Mailed
Mar 15, 2022
Non-Final Action E-Mailed
Mar 15, 2022
Non-Final Action Written
Mar 15, 2022
Assigned To Examiner
Sep 8, 2021
New Application Office Supplied Data Entered
Jun 26, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
